LAUREN HUNT: Open Payments
NPI 1093480295 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,301 in 119 payments from 44 companies in 2025. Trend: 2023 $3,180 · 2024 $2,753 · 2025 $3,301
Food & beverage: $3,102Education: $200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $409 |
| Janssen Biotech, Inc. | 10 | $296 |
| Novartis Pharmaceuticals Corporation | 10 | $296 |
| Regeneron Healthcare Solutions, Inc. | 5 | $246 |
| Merck Sharp & Dohme LLC | 5 | $149 |
| Celgene Corporation | 5 | $130 |
| GENZYME CORPORATION | 4 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $111 |
| Eisai Inc. | 4 | $106 |
| Astellas Pharma US Inc | 1 | $100 |
Products named: LIBTAYO, REBLOZYL, ERLEADA, IMFINZI, TAGRISSO, KISQALI, KEYTRUDA, Nubeqa.
Industry payments across TN — which companies pay providers there.
